Lantheus

4:00 PM - 4:15 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104A

With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus (NASDAQ LNTH) is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com